Norm Campbell

Dr. Norman Campbell

BMedSc CM MD DSc (hon) FRCPC

Positions

Professor Emeritus of Medicine

Libin Cardiovascular Institute

Contact information

Phone number

Cell: 403 560-6418

Preferred method of communication

email

Background

Educational Background

Bach of Med Sci Medicine, Memorial University, 1978

Doctor of Medicine Medicine, Memorial University, 1980

FRCPC Medicine, Royal College of Physicians and Surgeons of Canada, 1985

Biography

Dr. Campbell is a General Internist, a Professor Emeritus of Medicine, Community Health Sciences and Physiology and Pharmacology and a member of the Libin Cardiovascular Institute of Alberta and O’Brien Institute of Public Health at the University of Calgary.

Dr. Campbell is currently

Consultant to the Pan American Health Organization Hearts in the America’s Initiative

Consultant to the Onom Foundation for hypertension control in Mongolia

Advisor to the Board of the World Hypertension League

Interim Chair of the Canadian Hypertension Coalition

Member International Advisory Board Australian Cardiovascular Alliance (ACvA)

Board member, Alberta Environment Network

Chair, Alberta Health Professionals for the Environment Working Group for the Alberta Environment Network

 

Dr Campbell has over 560 peer-reviewed manuscripts and over 500 national/ international invited presentations.

 

In the past, Dr Campbell has been

  • President of the World Hypertension League (2013-2015; League of national hypertension and cardiovascular organizations dedicated to global hypertension prevention and control).
  • President of Blood Pressure Canada, (1996-1999 and 2006-2010).
  • President of the Canadian Hypertension Society (1999-2000). 
  • Founder and Chair of the annual Canadian hypertension recommendations/control program 2000-2002, 2005-2010 (Canadian Hypertension Education Program).
  • President of the Canadian Society for Clinical Pharmacology (2002-2004)
  • Chair of the Pan American Health Organization / World Health Organization Regional Expert Group on Cardiovascular Disease Prevention through Dietary Salt Reduction (2009-2011).
  • Co-Chair of the Pan American Health Organization / World Health Organization Technical Advisory Group on Cardiovascular Disease Prevention through Dietary Salt Reduction (2012-2015).
  • Chair and Co-chair of the Vascular Risk Reduction program of the Alberta Health Services Strategic Clinical Networks (2012-2016),
  • Chair and Co-Chair of the ACTION network of Alberta Health Care Professional and Scientific Organizations to reduce the burden of cardiovascular disease (2013-2017).
  • Founder and Chair of the ‘TRUE’ international consortium of health and scientific organizations to develop standards for the conduct of clinical research on dietary salt.
  • Founder and initial Chair ‘Science of salt’ weekly review of the literature on dietary sodium and regular systematic critical appraisals of clinical research relating to the harms of dietary sodium and methods to reduce dietary salt.
  • Founder and Chair of the Canadian Hypertension Advisory Committee (2011-2016). Vice chair 2016-2019
  • HSF CIHR Chair in Hypertension Prevention and Control (2011-2016).
  • CHIR Canada Chair in Hypertension Prevention and Control (2006-2011).
  • Chair and Co-Chair of the integration committee to form Hypertension Canada from the Canadian Hypertension Society, Blood Pressure Canada and Canadian Hypertension Education Program.

Dr. Campbell obtained his MD from Memorial University in Newfoundland, where he also did his Internal Medicine residency. He went on to study Clinical Pharmacology at the Mayo Clinic supervised by Dr Richard Weinshilboum.

Awards

  • Emeritus member, International Society of Hypertension. 2023
  • Senior Investigator Award, Hypertension Canada. 2021
  • Excellence in leadership and distinguished service award, World Hypertension League.. 2019
  • Doctor of Science (honoris causa), Memorial University of Newfoundland. 2019
  • Enrique Barnet Prize in Public Health, Province of Cienfuegos, Cuba. 2018
  • World Hypertension League names an award the ‘Norman Campbell Excellence Award for Population Hypertension Prevention and Control, World Hypertension League. 2017
  • Excellence Award in Population Blood Pressure Control and Distinguished Service Award, World Hypertension League. 2016
  • Peaks Scholar, University of Calgary. 2015
  • Medal of Honour, Canadian Health Research Foundation. 2015
  • Medal for Distinguished Service, Alberta Medical Association. 2015
  • Letter of excellence, Hypertension Canada to the Canadian Hypertension Advisory Committee, Hypertension Canada. 2013
  • Frederic Newton Gisborne Starr Award, Canadian Medical Association. 2015
  • Member of the Order of Canada, Canadian Government. 2014
  • Fellowship in the Canadian Academy of Health Sciences, Canadian Academy of Health Sciences. 2014
  • Dr. Howard N. Segall Award of Merit, Canadian Cardiovascular Society. 2014
  • Distinguished Service Award, Canadian Hypertension Society. 2008
  • Distinguished Academic Award, Confederation of Alberta Faculty Associations. 2014
  • Team Builder of the Year Award, Department of Medicine, University of Calgary. 2014
  • Guenter Award for International Health, Faculty of Medicine, University of Calgary. 2013
  • JG Fodor Award, Hypertension Canada. 2010
  • HSF CIHR Canada Chair in Hypertension Prevention & Control, Heart and Stroke Foundation - Canadian Institute for Health. 2009
  • Special Distinguished Service Award, Canadian Hypertension Society. 2011
  • Distinguished Service Award, Canadian Hypertension Society. 2009
  • Sourirajan Lecture, Faculty of Medicine, University of Ottawa. 2008
  • Distinguished Speaker in Cardiovascular Medicine, Division of Cardiology. University of British Columbia. 2008
  • Leadership Award in Heart Healthy Policy, Heart and Stroke Foundation of Canada. 2007
  • CIHR Canada Chair in Hypertension Prevention & Control, Canadian Institute for Health Research. 2006
  • David Sackett Senior Investigator Award, Canadian Society of Internal Medicne. 2005
  • Distingished Service Award, Canadian Society of Clinical Pharmacology. 2005
  • Royal College of Physicians and Surgeons Lecturer , Canadian Society of Internal Medicine. 2003
  • Osler Award, Canadian Society of Internal Medicine. 2002
  • Letter for excellence in teaching, Calgary Medical Student Association. 2001
  • Grandfathered Specialist in Clinical Hypertension, American Hypertension Society. 2000
  • Gold Star Letter for excellence in lecturing, Faculty of Medicine, University of Calgary . 1998
  • Distinguished Achievement Award, Faculty of Medicine, The University of Calgary. 1996
  • Piafsky Young Investigator Award, Canadian Society for Clinical Pharmacology. 1995
  • Fellow of the American College of Physicians, 1990
  • Merck Foundation International Fellowship in Clinical Pharmacology, Merck Foundation. 1982
  • Robert B. Salter Award, Memorial University of Newfoundland. 1979
  • Atlantic Regional Athletic Bursary-Volleyball, Sports Canada. 1979
  • 2021